Analisis Efektivitas Biaya Pengobatan DM Nefropati di RSUD Panembahan Senopati Bantul

Putri Sumiyati; Eva Nurinda; Sofyan Indrayana; Eliza Dwinta

doi:10.21927/ijhaa.2025.8(1).54-64

Analisis Efektivitas Biaya Pengobatan DM Nefropati di RSUD Panembahan Senopati Bantul

Putri Sumiyati, Eva Nurinda, Sofyan Indrayana, Eliza Dwinta

Abstract

Diabetes mellitus is a group of metabolic diseases characterized by increased blood glucose. Diabetes mellitus can cause various chronic complications, one of which is diabetic nephropathy. The number of uses of treatment will cause differences in the effectiveness and cost of therapy.This study determined the cost effectiveness of nephropathy DM treatment in the Inpatient Ward of Panembahan Senopati Hospital, Bantul. This study was an analytic observational study with retrospective. Data collectional by looking at medical record and administrative data. As many as 63 respondent were inclusion criteria. The data obtained were analyzed using Microsoft Excel. Treatment effectiveness was measured based on patients who achieved ≤200 mg/dL Current Blood Sugar (GDS), while cost effectiveness was measured based on ACER and ICER values. The results showed that the effectiveness of drug B (non-insulin) was 88%, while drug A (insulin) was 85%. The average total cost of anti-diabetic drug B (non- insulin) is Rp. 839,563, and drug A (insulin) Rp. 1,163,473. drug group B (non- insulin) is more cost effective with an ACER value of Rp. 954,048, compared to drug A (insulin) of 1,368,791, in nephropathy DM patients at Panembahan Senopati Hospital, Bantul. The conclusion of this study shows that drug therapy group B (non- insulin) can be used as a cheaper and more effective treatment option for nephropathy DM patients

Keywords

Cost; DM nephropathy; Effectiveness; Outcome; CEA

Full Text:

PDF

References

Sukmadani Rusdi M. Hipoglikemia Pada Pasien Diabetes Melitus. J Syifa Sci Clin Res. 2020;2(2):83–90.

Association. AD. Standards of Medical Care in Diabetes. Diabetes Care [Internet]. 2020;44. Available from: https://doi.org/10.2337/dc21-SINT

Nurjanah E, Estiningsih D, Kusumawardani N, Hadi NS. Antibiotic Prescribing Pattern in Patients with Diabetes Mellitus Complications in Panembahan Senopati Bantul Hospital (Pola Peresepan Antibiotik pada Pasien Komplikasi Diabetes Melitus di RSUD Panembahan Senopati Bantul). J Ilmu Kefarmasian Indones. 2023;21(1):91–5.

Perkumpulan Endokrinologi Indonesia. Konsesus Pengolahan dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia. Perkeni 2019. 2019;1(69):5–24.

Federation ID. Annual Report 2023. 2023; Available from: www.cpcb.nic.in

Riset Kesehatan Dasar (Riskesdas). Laporan Riskesdas 2018 Nasional.pdf [Internet]. Lembaga Penerbit Balitbangkes. 2018. p. hal 156. Available from: https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf

Purwanti LE, Maghfirah S. Faktor Risiko Komplikasi Kronis (Kaki Diabetik) dalam Diabetes Mellitus Tipe 2. Indones J Heal Sci. 2016;7(1):26–39.

Hayul H, Andayani TM, Oetari. Analisis Kesesuaian Biaya Riil Terahadap Penetapan Tarif Ina-Cbg’S Pasien Nefropati Diabetik Rawat Inap Di Rsud Ir.Soekarno Sukoharjo Tahun 2018. J Farm Sains Indones. 2020;3(1):26–36.

Fitriyani F, Andrajati R, Trisna Y. Analisis Efektivitas-Biaya Terapi Kombinasi Metformin-Insulin dan Metformin-Sulfonilurea pada Pasien Rawat Jalan dengan Diabetes Melitus Tipe 2 di RSUPN Dr. Cipto Mangunkusumo. Indones J Clin Pharm. 2021;10(1):10.

Yuswantina R, Dyahariesti N. Analisis Efektivitas Biaya Penggunaan Antidiabetes Oral Tunggal dan Kombinasi Pada Pasien BPJS Penderita Diabetes Melitus Tipe 2 di Rumah Sakit X. Media Farm Indones [Internet]. 2018;13(1):1340–6. Available from: https://stifar.ac.id/ojs/index.php/MFI/article/view/47

Li Z, Zhu H, Pang X, Mao Y, Yi X, Li C, et al. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study. BMC Cancer [Internet]. 2022;22(1):1–11. Available from: https://doi.org/10.1186/s12885-022-10051-2

Parsaeian M, Mahdavi M, Saadati M, Mehdipour P, Sheidaei A, Khatibzadeh S, et al. Introducing an efficient sampling method for national surveys with limited sample sizes: application to a national study to determine quality and cost of healthcare. BMC Public Health. 2021;21(1):1–10.

Ramadhan N, Marissa N. Karakteristik Penderita Diabetes Mellitus Tipe 2 Berdasarkan Kadar Hba1C Di Puskesmas Jayabaru Kota Banda Aceh. Sel. 2015;2(2):49–56.

Marwanto P. Proporsi angka kejadian nefropati diabetik pada laki-laki dan perempuan penderita diabetes melitus tahun 2009 di Rsud Dr.Moewardi Surakarta. Univ Muhammadiyah Surakarta. 2010;1.

Arania Resti , Triwahyuni Tusy , Esfandiari Firhat NFR. HUBUNGAN ANTARA USIA, JENIS KELAMIN, DAN TINGKATPENDIDIKAN DENGAN KEJADIAN DIABETES MELLITUSDI KLINIK MARDI WALUYO LAMPUNG TENGAH. J Med Malahayat. 2021;5(3):146–53.

Sihotang RC, Ramadhani R, Tahapary DL. Efikasi dan Keamanan Obat Anti Diabetik Oral pada Pasien Diabetes Melitus Tipe 2 dengan Penyakit Ginjal Kronik. J Penyakit Dalam Indones. 2018;5(3):150.

Larasaty LPF, Dewantara Putra IGNA, Sarasmita MA. Total Biaya Terapi Insulin Pada Kasus Diabetes Mellitus Tipe 2 Rawat Jalan Di Kotamadya Denpasar. J Manaj DAN PELAYANAN Farm (Journal Manag Pharm Pract. 2017;7(1):1.

Marhenta YB, Aditya M, Siwi A, Aprilianur D. Analisis Efektifitas Biaya Terapi Kombinasi Antihipertensi Pasien Hipertensi dengan Penyerta Diabetes Mellitus Tipe-2 di RSU Aminah Blitar. J Wiyata [Internet]. 2018;5(1):44–51. Available from: https://www.wiyata.iik.ac.id/index.php/wiyata/article/view/203/122

Mas Ulfa N, Fandinata S, Puspitasari I. Analisis Efektifitas Biaya Terapi Pengobatan Pasien Diabetes Mellitus Tipe 2 terhadap Kontrol Glukosa Darah Cost Effectiveness Analysis of Treatment of Type 2 Diabetes Mellitus Patients on Blood Glucose Control. Junal Kefarmasian Indones [Internet]. 2023;13(1):83–94. Available from: https://doi.org./10.22

Anggraini A, Andayani TM, Ikawati Z. Perbandingan Efektivitas Glikuidon dengan Insulin pada Pengobatan Diabetes Pasien Penyakit Ginjal Kronik. Maj Farm. 2023;19(2):230–6.

Yosmar R, Ningsih L, Ifmaily. Studi Analisa Efektivitas Biaya pada Pasien Kanker Payudara yang Menjalani Kemoterapi di RSUP DR. M. Djamil Padang. J Farm Higea. 2020;12(1):19–31.

Shafrin J, Dennen S, Pednekar P, Birch K, Bhor M, Kanter J, et al. For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports. J Manag Care Spec Pharm. 2021;27(5):650–9.

DOI: http://dx.doi.org/10.21927/ijhaa.2025.8(1).54-64